Source-grounded facts extracted from Acadia Healthcare Company, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Acadia Healthcare Company, Inc. shareholders approved Ratification of independent registered public accounting firm at the 2026-05-06 meeting.
“The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, by the following vote: For Against Abstain 83,941,435 1,947,371 49,513”
Acadia Healthcare Company, Inc. shareholders approved Advisory vote on executive compensation at the 2026-05-06 meeting.
“The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers (as defined in the Company’s definitive proxy statement filed with the SEC on March 25, 2026), by the following vote: For Against Abstain Broker Non-Votes 60,889,503 19,942,924 103,408 5,002,484”
Acadia Healthcare Company, Inc. shareholders approved Approval of second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan at the 2026-05-06 meeting.
“The Company’s stockholders approved a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan, by the following vote: For Against Abstain Broker Non-Votes 80,102,444 779,641 53,750 5,002,484”
Acadia Healthcare Company, Inc. shareholders approved Election of Class III Directors at the 2026-05-06 meeting.
“The individuals listed below were elected to serve as Class III directors until the Company’s annual meeting of stockholders in 2029 or until their successors have been elected and take office. The voting results were as follows: For Against Abstain Broker Non-Votes Daniel J. Cancelmi 80,276,613 608,441 50,781 5,002,484 Michael J. Fucci 73,587,992 7,296,976 50,867 5,002,484 Patrice A. Harris, M.D., M.A. 80,535,426 350,255 50,154 5,002,484”
Acadia Healthcare Company, Inc. reported the first quarter ended March 31, 2026 results: revenue $828.8 million, net income $0.05 per diluted share, EPS $0.05 per diluted share. Guidance raised.
“Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Results ● Revenue totaled $828.8 million, a 7.6% increase compared with the first quarter of 2025 ● Same-facility revenue increased 7.3% compared with the first quarter of 2025, including an increase in revenue per”
Acadia Healthcare Company, Inc. incurred term loan of $650 million senior secured term loan facility with JPMorgan Chase Bank, N.A., as administrative agent at a SOFR-based rate plus a margin ranging from 1.375% to 2.250% or a base rate plu maturing February 28, 2030.
“The Credit Agreement provides for a $1 billion senior secured revolving credit facility (including a $50 million sublimit for the issuance of letters of credit and a $50 million swingline subfacility) (the “Revolving Facility”) and a $650 million senior secured term loan facility (the “Term Loan Facility” and, together with the Revolving Facility, the “Senior Facilities”), each scheduled to mature on February 28, 2030.”
Acadia Healthcare Company, Inc. incurred revolving credit of $1 billion senior secured revolving credit facility with JPMorgan Chase Bank, N.A., as administrative agent at a SOFR-based rate plus a margin ranging from 1.375% to 2.250% or a base rate plu maturing February 28, 2030.
“The Credit Agreement provides for a $1 billion senior secured revolving credit facility (including a $50 million sublimit for the issuance of letters of credit and a $50 million swingline subfacility) (the “Revolving Facility”) and a $650 million senior secured term loan facility (the “Term Loan Facility” and, together with the Revolving Facility, the “Senior Facilities”), each scheduled to mature on February 28, 2030.”
Nasser Khan was appointed as Chief Operating Officer at Acadia Healthcare Company, Inc..
“Appointment of Dr. Nasser Khan as Chief Operating Officer On May 23, 2024, Acadia Healthcare Company, Inc. (the “Company”) announced the appointment of Dr. Nasser Khan as the Chief Operating Officer of the Company, effective June 30, 2024.”
Acadia Healthcare Company, Inc. reported first quarter ended March 31, 2024 results: revenue $768.1 million, net income $76.4 million, EPS $0.83 per diluted share. Guidance reaffirmed.
“2024 ) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2024. First Quarter Highlights ● Revenue totaled $768.1 million, an increase of 9.1% over the first quarter of 2023 ● Same facility revenue increased 9.2% compared with the first quarter of 2023, including an increase in revenue per patient”
Acadia Healthcare Company, Inc. reported financial results for fourth quarter and year ended December 31, 2023.
“On February 27, 2024, Acadia Healthcare Company, Inc. (“Acadia”) issued a press release announcing, among other things, Acadia’s operating and financial results for the fourth quarter and year ended December 31, 2023.”
Acadia Healthcare Company, Inc. amended Amended Credit Agreement with Bank of America, N.A. valued at $350 million Incremental Term Loans under existing $425 million Term Loan Facility and $600 million (effective 2024-01-18).
“On January 18, 2024, Acadia Healthcare Company, Inc. (the " Company ") and the Guarantors (as defined below) entered into that certain Amendment No. 2 to Credit Agreement (the " Amendment ") with Bank of America, N.A., as administrative agent (the " Administrative Agent ") and certain lenders party thereto, which amends the Credit Agreement, dated as of March 17, 2021, among the Company, the Administrative Agent and the lenders from time to time party thereto”
Acadia Healthcare Company, Inc. reported the third quarter ended September 30, 2023 results: revenue $750.3 million, net income $217.7 million, EPS $2.39 per diluted share.
“Acadia Healthcare Company, Inc. (“Acadia”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights Revenue totaled $750.3 million”
Acadia Healthcare Company, Inc. entered into Settlement Agreements valued at an aggregate amount of $400 million (effective 2023-10-30).
“On October 30, 2023, Acadia Healthcare Company, Inc. (“Acadia” or “the Company”) and its subsidiary Youth and Family Centered Services of New Mexico (“Desert Hills”) entered into settlement agreements (collectively, the “Settlement Agreements”) in connection with Acadia and Desert Hills’ previously disclosed civil litigation in New Mexico State District Court”
Patrice A. Harris was elected as Director at Acadia Healthcare Company, Inc..
“Effective October 26, 2023, the Board of Directors (the “Board”) of Acadia Healthcare Company, Inc. (the “Company”) increased the number of Class III directors serving on the Board from two to three and elected Patrice A. Harris, M.D., M.A. to fill the vacancy created by the increase in the number of Class III directors.”
Acadia Healthcare Company, Inc. reported the second quarter ended June 30, 2023 results: revenue $731.3 million, net income $72.3 million, EPS $0.79 per diluted share. Guidance raised.
“Company, Inc. (“Acadia”) (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2023. Second Quarter and Recent Highlights Revenue totaled $731.3 million, an increase of 12.2% over the second quarter of 2022 Same facility revenue increased 11.4% compared with the second quarter of 2022, including an increase in revenue per patient”
David Duckworth resigned as Chief Financial Officer at Acadia Healthcare Company, Inc..
“the Company announced that David Duckworth will resign as Chief Financial Officer, effective July 10, 2023.”
Chris Howard retired as Executive Vice President, General Counsel and Secretary at Acadia Healthcare Company, Inc..
“Chris Howard, currently Executive Vice President, General Counsel and Secretary, will retire from his position effective July 26, 2023.”
Brian Farley was appointed as Executive Vice President and General Counsel at Acadia Healthcare Company, Inc..
“On June 30, 2023, Acadia Healthcare Company, Inc. (the “Company”) appointed Brian Farley as the Executive Vice President and General Counsel of the Company, effective July 26, 2023.”
Heather Dixon was appointed as Chief Financial Officer at Acadia Healthcare Company, Inc..
“On June 1, 2023, Acadia Healthcare Company, Inc. (the “Company”) appointed Heather Dixon as the Chief Financial Officer of the Company, effective July 10, 2023.”
Acadia Healthcare Company, Inc. shareholders approved Ratification of independent registered public accounting firm at the 2023-05-18 meeting.
“The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, by the following vote: For Against Abstain 87,880,701 576,757 21,853”
Acadia Healthcare Company, Inc. shareholders approved Non-binding advisory vote on named executive officer compensation at the 2023-05-18 meeting.
“The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers (as defined in the Company’s definitive proxy statement filed with the SEC on April 7, 2023), by the following vote: For Against Abstain Broker Non-Votes 85,589,978 1,132,077 21,821 1,735,435”
Acadia Healthcare Company, Inc. shareholders approved Amendment and restatement of the Incentive Compensation Plan at the 2023-05-18 meeting.
“The Company’s stockholders approved an amendment and restatement of the Acadia Healthcare Company, Inc. Incentive Compensation Plan, by the following vote: For Against Abstain Broker Non-Votes 85,187,311 1,532,139 24,426 1,735,435”
Acadia Healthcare Company, Inc. shareholders approved Election of Class III Directors at the 2023-05-18 meeting.
“The individuals listed below were elected to serve as Class III directors until the Company’s annual meeting of stockholders in 2026 or until their successors have been elected and take office. The voting results were as follows: For Against Abstain Broker Non-Votes Michael J. Fucci 74,423,272 12,296,852 23,752 1,735,435 Wade D. Miquelon 65,692,075 21,027,841 23,960 1,735,435”
Acadia Healthcare Company, Inc. reported the first quarter ended March 31, 2023 results: revenue $704.3 million, net income $66.0 million, EPS $0.72 per diluted share. Guidance reaffirmed.
“The Company reported revenue of $704.3 million for the first quarter of 2023, compared with $616.7 million for the first quarter of 2022.”
Acadia Healthcare Company, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $675.3 million, net income $61.1 million, EPS $0.67 per diluted share. Guidance initiated.
“Revenue totaled $675.3 million, an increase of 13.8% over the fourth quarter of 2021 Same facility revenue increased 9.4% compared to the fourth quarter of 2021, including an increase in revenue per patient day of 5.2% and an increase in patient days of 4.0% Net income attributable to Acadia totaled $61.1 million, or $0.67 per diluted share”
Acadia Healthcare Company, Inc. reported third quarter ended September 30, 2022 results: revenue $666.7 million, net income $71.1 million, EPS $0.78 per diluted share.
“The Company reported revenue of $666.7 million for the third quarter of 2022, compared with $587.6 million for the third quarter of 2021.”
Acadia Healthcare Company, Inc. reported the third quarter ended September 30, 2022 results: revenue $666.7 million, net income $71.1 million, EPS $0.78 per diluted share.
“The Company reported revenue of $666.7 million for the third quarter of 2022, compared with $587.6 million for the third quarter of 2021. Adjusted EBITDA was $162.8 million for the third quarter of 2022, compared with $141.9 million for the same period last year. Excluding income from the PRF, Adjusted EBITDA was $155.1 million for the third quarter of 2022. The Company recorded income from the PRF of $7.7 million in the third quarter of 2022. The Company will continue to review the remaining $14.2 million of American Rescue Plan (“ARP”) Rural Payments held on its balance sheet as of September 30, 2022, for the potential recognition of additional income. Financial guidance for 2022 does not include the recognition of additional income in the fourth quarter of 2022 beyond the $16.2 million recorded in the nine months ended September 30, 2022. Net income attributable to Acadia stockholders for the third quarter of 2022 was $71.1 million, or $0.78 per diluted share.”
R. David Kelly was elected as Class II director at Acadia Healthcare Company, Inc..
“Effective June 28, 2022, the Board of Directors (the “Board”) of Acadia Healthcare Company, Inc. (the “Company”) increased the number of Class II directors serving on the Board from three to four and elected R. David Kelly to fill the vacancy created by the increase in the number of Class II directors.”
Christopher H. Hunter was appointed as Chief Executive Officer and Director at Acadia Healthcare Company, Inc..
“appointed Christopher H. Hunter as the Company’s new Chief Executive Officer and as a member of the Board, effective April 11, 2022.”
Debbie Osteen departed as Chief Executive Officer at Acadia Healthcare Company, Inc..
“announced that Debbie Osteen, Chief Executive Officer and Director of the Company, will retire as Chief Executive Officer and that it was anticipated that Ms. Osteen’s retirement would be effective on January 31, 2022.”
Debbie Osteen departed as Chief Executive Officer at Acadia Healthcare Company, Inc..
“announced that Debbie Osteen, Chief Executive Officer and Director of the Company, will retire as Chief Executive Officer.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.